Wednesday, July 30, 2025
As Crimean-Congo Haemorrhagic Fever (CCHF) cases surge in Spain and Greece, health authorities have been forced to confront an alarming rise in the deadly virus, which is now spreading beyond its historical regions in Africa and Asia. This unprecedented increase in cases has prompted urgent global health alerts, with experts attributing the rapid spread to rising temperatures and the expansion of tick populations, which carry the virus. The outbreak’s escalation in these European countries highlights the growing risk of CCHF becoming a wider public health threat. With no specific antiviral treatment available and a fatality rate ranging from 10 to 40 percent, swift and coordinated international action is crucial to contain the spread and prevent further fatalities.
Rising Cases of Crimean-Congo Haemorrhagic Fever in Spain and Greece Prompt Global Concern
An urgent health alert has been issued following an alarming increase in cases of Crimean-Congo Haemorrhagic Fever (CCHF) in Spain and Greece. This viral disease, which has a fatality rate ranging from 10 to 40 percent, is spreading in certain regions, with some areas now classified as hotspots. As of late July 2025, both countries have reported confirmed instances of the disease, drawing the attention of health authorities across Europe and globally.
CCHF, a serious illness caused by the Nairovirus, is transmitted to humans primarily through tick bites. The disease has historically been endemic to Africa, parts of the Balkans, the Middle East, and Asia. However, the emergence of cases in Europe, including Spain and Greece, is raising concerns about the potential for the disease to spread further across the continent. Experts are pointing to climate change as a contributing factor, as rising temperatures may be allowing ticks to thrive in areas that were previously unsuitable for them, thus expanding the reach of the virus.
Understanding Crimean-Congo Haemorrhagic Fever
The UK Health Security Agency estimates that globally, there are between 10,000 and 15,000 reported cases of human infection annually. Of these, around 500 result in fatalities, although the true numbers could be higher due to underreporting. The virus is typically transmitted through ticks, but it can also spread through contact with infected animal blood, tissue, or bodily fluids.
Crimean-Congo Haemorrhagic Fever was first documented in 1944 in Crimea, where it affected soldiers and farm workers. By 1969, scientists had linked the virus to a pathogen originally isolated from a Congolese child in 1956. The World Health Organization (WHO) has since classified CCHF as one of its nine “priority diseases,” recognizing the substantial threat it poses to global public health.
Symptoms and Severity of CCHF
The disease manifests with a variety of symptoms, often beginning suddenly with severe headaches, fever, and general body aches. These initial symptoms are commonly accompanied by joint pain, abdominal discomfort, and nausea. Other common signs of CCHF include red or bloodshot eyes, facial flushing, throat redness, and small red spots known as petechiae, which often appear on the roof of the mouth.
In more critical cases, individuals may develop jaundice, characterized by a yellowing of the skin, along with mood swings and altered sensory perception. As the illness progresses, individuals may develop severe bruising, nosebleeds, and excessive bleeding at injection sites, which can occur as early as the fourth day of illness. In some cases, the hemorrhaging becomes uncontrollable and may continue for up to two weeks.
The progression of the disease can be rapid, with mortality rates for hospitalized patients varying widely. Historical outbreaks have seen mortality rates between 9% and as high as 50%. These numbers highlight the importance of prompt diagnosis and timely treatment.
Global Threat and Changing Patterns
While Crimean-Congo Haemorrhagic Fever has traditionally been associated with regions of Africa and Asia, the spread of the disease to Europe has raised alarms among health experts. The increasing frequency of outbreaks in countries like Spain and Greece suggests that the disease may be moving beyond its typical territories. Many experts believe that climate change plays a significant role in this shift. Warmer temperatures can extend the range of ticks that carry the virus, allowing them to inhabit new areas, including parts of Western Europe.
The rise in CCHF cases is particularly concerning because of the virus’s high fatality rate and the limited availability of effective treatment options. Currently, there is no specific antiviral treatment for CCHF, and supportive care remains the primary form of medical intervention. Early detection and immediate medical care are crucial in improving survival rates, but the disease can be difficult to diagnose in its early stages, as its symptoms resemble those of other more common illnesses.
WHO’s Priority on CCHF
The World Health Organization’s classification of CCHF as a “priority disease” highlights the significant threat the virus poses, particularly as the disease continues to spread beyond its historical hotspots. The WHO is working closely with local health authorities to monitor the situation and provide guidance on controlling the spread of the virus.
Preventive measures are focused primarily on reducing human exposure to ticks, which involves avoiding tick-infested areas, using insect repellent, and wearing protective clothing. For those in high-risk areas, surveillance of livestock and other animals is essential, as animals can act as reservoirs for the virus. In addition, controlling outbreaks often requires isolating infected individuals and ensuring that healthcare workers use appropriate protective equipment to prevent transmission.
As Crimean-Congo Haemorrhagic Fever cases rise in Spain and Greece, global health authorities are on high alert due to the rapid spread of the virus, driven by climate change and expanding tick populations. With no effective antiviral treatment, swift international intervention is critical to prevent further outbreaks.
The rise in Crimean-Congo Haemorrhagic Fever cases in Spain and Greece serves as a stark reminder of the increasing global health risks posed by vector-borne diseases. As the virus continues to spread, especially in light of climate change, countries across Europe and beyond must remain vigilant in monitoring and controlling outbreaks. Early detection, prompt medical intervention, and public awareness will be key factors in managing the impact of this deadly disease and preventing its further spread.
